BioNexus Gene Lab Corp (BGLC)
NASDAQ
$1.67+0.60%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 2,048
- 52-week high
- —
- 52-week low
- —
- Open
- $1.67
- Day high
- $1.67
- Day low
- $1.67
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $7.42M | -$2.98M | — |
| 2024 | $9.51M | -$1.6M | -$0.09 |
| 2023 | $9.77M | -$2.63M | -$0.17 |
| 2022 | $10.93M | -$355.97K | — |
| 2021 | $13.36M | $751.57K | — |
About BioNexus Gene Lab Corp
A company overview for BioNexus Gene Lab Corp is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is BioNexus Gene Lab Corp's stock price today?
- BGLC is trading at $1.67 as of Jul 20, 2026.
- Does BioNexus Gene Lab Corp pay a dividend?
- BioNexus Gene Lab Corp did not pay a dividend in its most recent reported fiscal year.